The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organaics Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Virupaksha Organics Ltd, part of the promoter/promoter group of Oxygenta Pharmaceutical Ltd, acquired 1,00,000 equity shares (0.27%) of the company on May 30, 2025 through an off-market Share Purchase Agreement dated September 30, 2024. Before this acquisition, the promoter entity held 1,06,24,858 shares (28.73%) and after the buy, its holding has risen to 1,07,24,858 shares (29.00%). This is part of a series of creeping acquisitions by the same promoter entity during April-May 2025, with multiple share transfers already disclosed (totaling over 1.06 crore shares in that period). No encumbrance or pledge is involved in this transaction.
The promoter group is steadily increasing its stake from 28.73% to 29.00% and is now within 1 percentage point of the 30% open offer trigger threshold under SEBI takeover rules, which could lead to further disclosures or a potential open offer requirement. For retail shareholders, this signals continued promoter confidence in the company, but also means the promoter is consolidating ownership.